designer491/iStock via Getty Images
Valneva SE (NASDAQ:VALN) said on Thursday that the FDA has lifted its pause on the use of its chikungunya vaccine, Ixchiq, for individuals aged 60 and older and has updated the prescribing information for the vaccine.
This decision follows a